These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 1888267)

  • 1. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XV: Antithrombotic effect of selected oligoamines in rats.
    Rehse K; Kesselhut A; Schein V; Kämpfe M; Rose B; Unsöld E
    Arch Pharm (Weinheim); 1991 May; 324(5):301-5. PubMed ID: 1888267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVI: Antiplatelet and antithrombotic effects of the oligoamine RE 1492 in combination with standard and future antithrombotic drugs.
    Rehse K; Ciborski T
    Arch Pharm (Weinheim); 1995 Apr; 328(4):333-7. PubMed ID: 7611829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiaggregatory and anticoagulant effects of oligoamines. 10. Tertiary oligoamines and quaternary ammonium salts].
    Rehse K; Kämpfe M
    Arch Pharm (Weinheim); 1989 Nov; 322(11):811-5. PubMed ID: 2624527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVIII: Oligoamines with fluorescent properties. Part C: Fluorescent oligoamines with enhanced hydrophilic properties.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1995 Feb; 328(2):131-5. PubMed ID: 7726738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-aggregatory and anticoagulant properties of oligoamines. 11. Oligoamines with two primary amine groups].
    Rehse K; Rose B; Leissring S
    Arch Pharm (Weinheim); 1990 Feb; 323(2):103-8. PubMed ID: 2334273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antiaggregative and anticoagulant effects of oligoamines. 8. Oligoamines with N-heterocyclic space structures].
    Rehse K; Mletzko S
    Arch Pharm (Weinheim); 1988 Sep; 321(9):533-6. PubMed ID: 3240067
    [No Abstract]   [Full Text] [Related]  

  • 7. New NO-donors with antithrombotic and vasodilating activities, VIII: Benzothiazole-2(3H)-nitrosimines.
    Rehse K; Ciborski T; Lüdtke E
    Arch Pharm (Weinheim); 1994 Dec; 327(12):771-7. PubMed ID: 7872854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antiaggregatory and anticoagulant effects of oligoamines. 7. Benzene-1,3,5-trialkaneamines].
    Rehse K; Lükens U; Claus G
    Arch Pharm (Weinheim); 1987 Dec; 320(12):1233-8. PubMed ID: 3439865
    [No Abstract]   [Full Text] [Related]  

  • 9. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXII: Bisoxazol-, bisimidazol-, bisthiazol- and oligo-1,2,4-thiadiazolimines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Jul; 326(7):399-404. PubMed ID: 8357302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVII: Oligoamines with fluorescent properties. Part A: Fluorescent bridged nitrogen functions.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1992 Apr; 325(4):235-9. PubMed ID: 1530456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XX: 4,4',4''-(1,3,5)-benzene-tris-sydnone imines.
    Rehse K; Martens A
    Arch Pharm (Weinheim); 1993 Apr; 326(4):217-9. PubMed ID: 8494483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVIII: Oligoamines with fluorescent properties, Part B: Fluorophores in the molecular periphery.
    Rehse K; Seidel T
    Arch Pharm (Weinheim); 1994 Jun; 327(6):399-404. PubMed ID: 8048847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, Part 33. From tetradecane- to octacosanediamines.
    Rehse K; Nolte-Driller R
    Arch Pharm (Weinheim); 1996 Apr; 329(4):191-6. PubMed ID: 8669983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XXVII. Inhibition of leucocyte adherence to endothelium by the oligoamine RE 1492C and the NO-donor RE 2047.
    Rehse K; Ciborski T; Müller B
    Arch Pharm (Weinheim); 1995 Feb; 328(2):125-6. PubMed ID: 7726736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New NO donors with antithrombotic and vasodilating activities, part 25. Hydroxylamine derivatives.
    Rehse K; Shahrouri T
    Arch Pharm (Weinheim); 1998 Nov; 331(11):365-7. PubMed ID: 9881060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2-Nitrosoimino-3,6-dihydro-2H-1,3,4-thiadiazines with antiplatelet and antithrombotic properties.
    Rehse K; Brümmer U; Unsöld E
    Pharmazie; 1998 Dec; 53(12):820-4. PubMed ID: 9879566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New NO-donors with antithrombotic and vasodilating activities, XII: Mesoionic oxatriazoles and related noncyclic nitrosohydrazine derivatives.
    Rehse K; König P
    Arch Pharm (Weinheim); 1995 Feb; 328(2):137-42. PubMed ID: 7726739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiaggregating and antithrombotic activities of new 1, 2, 3-triazolecarboxamides.
    Cwiklicki A; Rehse K
    Arch Pharm (Weinheim); 2004 Mar; 337(3):156-63. PubMed ID: 15038061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XVI: Cytostatic and cytotoxic side effects of oligoamines.
    Rehse K; Noack B; Maurer R; Hilgard P
    Arch Pharm (Weinheim); 1991 Oct; 324(10):797-801. PubMed ID: 1805711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet aggregation inhibiting and anticoagulant effects of oligoamines, XIX: 4,4'-Phenylene-bis-sydnone imines.
    Rehse K; Kämpfe M; Martens A
    Arch Pharm (Weinheim); 1993 Mar; 326(3):163-6. PubMed ID: 8481095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.